/
GERM
$19.16-$0.06 (-0.29%)prev close
Change$-25.00
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Asset Management
ETFMG Treatments, Testing and Advancements ETF
This fund aims to replicate the investment performance of U.S.-listed companies, including equity shares and depositary receipts, that are primarily engaged in two sectors: either researching, developing, and bringing to market treatments or vaccines for infectious diseases, or producing, researching, and supplying biological diagnostic tests for patients. At least 80% of the fund's total assets will be invested in the specific securities that constitute its underlying index. It is important to note that this fund is structured as non-diversified.
- IPO / List date
- Jun 18, 2020
- HQ
- US
Held by traders on TradeandTell
No one on the platform currently holds GERM.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GERM as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 1.23% ($0.24/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2024-06-27 | $0.0880 | 2024-06-28 |
| 2024-03-26 | $0.0558 | 2024-03-28 |
| 2023-12-27 | $0.0522 | 2023-12-29 |
| 2023-09-20 | $0.0400 | 2023-09-22 |
Recent trades on TradeandTell
No one on the platform has traded GERM yet.
